LCMV gp peptide SGVENPGGYCL (H-2 Db)
IBA Lifescience Kontakt z doradcąSingle peptide synthesized as presented by the MHC class I allele
LCMV gp(276-286) peptide SGVENPGGYCL (H-2 Db) is a single peptide for stimulation of T cells. The peptide from lymphocytic choreomeningitis virus (LCMV) glycoprotein (gp) is synthesized as it is presented by the MHC class I H-2 Db allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.
Specifications
- Form: Lyophilized powder
- Peptide Sequence: SGVENPGGYCL
- Possible Application: T cell stimulation
- Purity: > 85%
- Sterility: Sterile
- MHC I Compatibility: H-2 Db
